SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.0830
+0.0010 (1.22%)
At close: Sep 26, 2025
SoftOx Solutions AS Revenue
SoftOx Solutions AS had revenue of 4.29M NOK in the quarter ending June 30, 2025, with 40.14% growth. This brings the company's revenue in the last twelve months to 10.54M, up 535.18% year-over-year. In the year 2024, SoftOx Solutions AS had annual revenue of 7.91M with 13.38% growth.
Revenue (ttm)
10.54M
Revenue Growth
+535.18%
P/S Ratio
16.91
Revenue / Employee
5.27M
Employees
2
Market Cap
178.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.91M | 934.00K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | 9.84M | 5.74M | 140.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Photocure ASA | 522.86M |
| ArcticZymes Technologies ASA | 104.33M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| Nykode Therapeutics AS | 79.85M |